Dr. Miller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Vagelos College of Physicians and Surgeons at Columbia University
630 West 168th Street, PH15-124
New York, NY 10032Phone+1 212-305-4531Fax+1 212-305-4548
Summary
- As of July 2022, I am an attending neuropathologist at the NewYork–Presbyterian Hospital/Columbia University Irving Medical Center, with an appointment as assistant professor of pathology in the Department of Pathology and Cell Biology at the Vagelos College of Physicians and Surgeons.
In June 2022, I completed my post-graduate clinical training in both anatomic pathology and neuropathology, both at Columbia University Irving Medical Center through their combined AP/NP residency-fellowship training program.
In May 2018, I completed my graduate training in the Icahn School of Medicine at Mount Sinai's (ISMMS) medical-scientist training program (MSTP), receiving doctoral degrees in medicine and neuroscience. My doctoral thesis in Neuroscience, successfully presented to my committee in Spring 2016, was conducted in the Laboratory of Molecular Neuropsychopharmacology, Friedman Brain Institute, under the supervision of Yasmin L. Hurd, professor of Psychiatry, Neuroscience and Pharmacology at the Icahn School of Medicine at Mount Sinai, and director of the Addiction Institute at Mount Sinai.
I graduated from Binghamton University in 2010 with degrees in Biochemistry and Integrative Neuroscience, and a certificate in evolutionary studies.
Education & Training
- New York Presbyterian Hospital (Columbia Campus)Fellowship, Neuropathology, 2020 - 2022
- New York Presbyterian Hospital (Columbia Campus)Residency, Pathology-Anatomic and Clinical, 2018 - 2020
- Icahn School of Medicine at Mount SinaiClass of 2018, MD, PhD
- Binghamton UniversityBS, Integrative Neuroscience, biochemistry and evolutionary studies, Summa Cum Laude, 2006 - 2010
Certifications & Licensure
- NY State Medical License 2021 - 2025
- American Board of Pathology Anatomic Pathology
- American Board of Pathology Neuropathology
Awards, Honors, & Recognition
- Shelanski Research Innovation Award Department of Pathology and Cell Biology, 2021
- Ruth L. Kirschstein National Research Service Award Fellowship National Institute on Drug Abuse, 2015-2018
- Goldwater Scholar The Barry M. Goldwater Scholarship and Excellence in Education Foundation, 2009
Publications & Presentations
PubMed
- 136 citationsCannabis Use during Adolescent Development: Susceptibility to Psychiatric Illness.Benjamin Chadwick, Michael L. Miller, Yasmin L. Hurd
Frontiers in Psychiatry. 2013-10-14 - 246 citationsCOVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital.Kiran T. Thakur, Emily Happy Miller, Michael D. Glendinning, Osama Al-Dalahmah, Matei A. Banu
Brain. 2021-10-22 - 130 citationsParental THC exposure leads to compulsive heroin-seeking and altered striatal synaptic plasticity in the subsequent generation.Henrietta Szutorisz, Jennifer A. DiNieri, Eric S. Sweet, Gabor Egervari, Michael Michaelides
Neuropsychopharmacology. 2014-05-01
Press Mentions
- A Gene Links Impulsivity and Drug Use VulnerabilityJune 14th, 2018
- Michael Miller Wins 2021 Shelanski Research Innovation Award in PathologyAugust 23rd, 2022
Grant Support
- Identifying distinct striatonigral and striatopallidal disturbancesNational Institute on Drug Abuse (NIDA/NIH)2015–2018
Professional Memberships
- NeuroplexMember
- AANPMember
External Links
- Websitehttp://michael-l-miller-mdphd.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: